intergroup rhabdomyosarcoma study post-surgical clinical group iia: localized tumor, gross total resection, but with microscopic residual disease
intergroup rhabdomyosarcoma study post-surgical clinical group iiib: localized or locally extensive tumor, gross residual disease after major resection (greater than 50 percent debulking)